Funds

BVP Fund IV

BVP Fund IV was established in April 2021. Limited partners of the fund are DSM Nederland, NV LIOF, Limburg Province and Rabobank. The fund size at first closing is € 45 million. The Rijksdienst voor Ondernemend Nederland (RVO) has committed € 10 mln out of the Seedcapitalregeling.  The fund’s life is 12 years with an investment period of 6 years during which it aims to invest in up to 15-20 companies.

BVP FundIV invests in innovative companies with a link to the Brightlands ecosystem. The Brightlands ecosystem has its root in four centers of gravity:

  • Chemistry and circularity R&D and production around the Brightlands Chemelot Campus in Geleen
  • Academic biomedical R&D at the Brightlands Maastricht Health Campus
  • Agrifood technologies and nutrition R&D at the Brightlands Campus Greenport Venlo
  • Data Science and smart services at the Brightlands Smart Services Campus in Heerlen

The Brightlands ecosystem has developed around these four campuses, with ties to strongholds in Eindhoven, Aachen and Leuven, Brightlands was built on the strengths of world leading innovative industrial companies such as BASF, Fresenius, Lonza and Saudi Aramco and a myriad of young innovative companies and R&D institutes.

For more information about Brightlands visit: http://www.brightlands.com

Facts & Figures

Legal nameBrightlands Venture Partners Fund IV
Start2021
DomicileThe Netherlands
Limited partnersDSM Nederland BV, NV LIOF, Province of Limburg, Coöperatieve Rabobank U.A.
TypeClosed-end fund
Size€ 45 million at first closing
Investment focus by sectorRenewable chemistry & circularity, regenerative medicine & biomedical materials, agritech & food and supportive digital technologies
Investment focus by stageEarly stage as well as later stage
EcosystemFit with the Brigthlands Ecosystem

Selected portfolio companies

Vivalyx

Organ preservation technology

ReSolved Technologies

Advanced solvent-based recycling of engineering plastics and soft pvc

Aliform

Medical devices for minimally-invasive skin surgery

Brightlands Agrifood Fund

Brightlands Agrifood Fund was established in 2017 to include agrifood technology startups in our  focus. This was triggered by the fast growth of the Brightlands Campus Greenport Venlo. Limited partners of the fund are Rabobank, Province of Limburg, NV LIOF, LLTB (Limburgse Land- en Tuinbouwbond), Van Herk Ventures and an undisclosed private individual active in modern greenhouse farming. The Rijksdienst voor Ondernemend Nederland (RVO) has committed € 6 million out of the so-called Seedcapitalregeling. More facts can be viewed below:

Facts & Figures

Legal nameBrightlands Agrifood Fund BV
Start2017
DomicileThe Netherlands
Limited partnersCoöperatieve Rabobank U.A., Province of Limburg, NV LIOF, LLTB (Limburgse Land- en Tuinbouwbond), Van Herk Ventures, a private individual active in modern greenhouse farming, and fund management
TypeClosed-end fund
Size€ 20.1 million
Investment focus by sectorAgriculture (seed & grow) and food (harvest & formulate)
Investment focus by stageEarly stage, including the ‘seed’ phase

Selected portfolio companies

Greencovery

Upcycling valuable ingredients from food production side-streams

S&dB

Plant seed-embedding technology

Pectcof

Functional food ingredients from coffee

Chemelot Ventures

Chemelot Ventures was established as a successor to Limburg Ventures in 2014. Limited partners of the fund are DSM Nederland, NV LIOF, Limburg Province and Rabobank, each with a commitment of € 10 million. The fund’s life is 12 years with an investment period of six years during which it has invested in 19 companies.

Facts & Figures

Legal nameChemelot Ventures BV
Start2014
DomicileThe Netherlands
Limited partnersDSM Nederland BV, NV LIOF, Province of Limburg, Coöperatieve Rabobank U.A.
TypeClosed-end fund
Size€ 40 million
Investment focus by sectorSustainable chemicals & materials, regenerative medicine & biomedical materials and diagnostics & analytics
Investment focus by stageEarly stage as well as later stage

Selected portfolio companies

Fuenix

Chemical recycling of mixed plastic waste

Neuroplast

Autologous stem cell therapies for neurodegenerative diseases

Vacis

Synthetic rod technology forming fully functional blood vessels

Limburg Ventures

Limburg Ventures is the predecessor fund of Chemelot Ventures. It was set up in 2004 and made 22 investments. The active investment period is over and is in its exit phase. It has realized several successful exits and still has a number of participations in its portfolio. Below you will find an overview of the most relevant facts regarding Limburg Ventures:

Facts & Figures

Legal nameLimburg Ventures BV
Start2004
DomicileThe Netherlands
Limited partnersDSM Nederland BV, NV LIOF
TypeClosed-end fund
Size€ 15 million
Investment focus by sectorLife sciences (regenerative medicine, drug delivery, drug screening, and formulation and diagnostics), advance materials ((bio-based) polymers and coatings, processing and applications)
Investment focus by stageEarly stage (in principle, past the ‘seed’ phase)

Selected portfolio companies

Pharmalot

National, generic pharmacy preparations to dispensing pharmacists

Kriya Materials

High performance coatings

Fortimedix Surgical

Endoscopic instruments and related equipment

More information

If you have any questions or want to know more about us
Contact us